Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Title Grant Type Focus Area Country Application Due Date Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Review Process:Improving the Clinical Management of Uncontrolled AcromegalyRelease Date:Review Process:Antimicrobial Stewardship in the Asia-Pacific RegionRelease Date:Review Process:Lysosomal Storage Disorders Fellowship for Nurse PractitionersRelease Date:Review Process:Hemophilia PUP RegistryRelease Date:Review Process:Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and ManagementRelease Date:Review Process:Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Review Process:Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic ArthritisRelease Date:Review Process:Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)Release Date:Review Process:Medication Optimization in Primary CareRelease Date:Review Process:Quality Improvement Activities to Prevent Fatal Pulmonary ThromboembolismRelease Date:Review Process:Increasing Rates of BRCA Testing in Patients with Breast CancerRelease Date:Review Process: